For example, KLF6 is the downstream target of miR-342-p in pancreatic cancer cells, whereby stable expression of KLF6 reduced the cancer cells’ viability and increased the sensitivity to gemcitabine [144]. The gene discussed is KLF6; the disease is pancreatic neoplasm.